This article was originally published in The Tan Sheet
Joseph Tempio, director of development and scientific affairs, resigns effective Sept. 6 to join contract research organization Bio-Pharm Pharmaceutical Services as VP of technology operations. Tempio has been a member of NDMA's Scientific Affairs Committee since 1991 and prior to joining Lederle in 1990, was director of scientific affairs for SmithKline Beecham Consumer
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC